Edition:
United States

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

1.90USD
18 Oct 2018
Change (% chg)

$-0.04 (-2.06%)
Prev Close
$1.94
Open
$1.95
Day's High
$1.95
Day's Low
$1.86
Volume
30,160
Avg. Vol
82,463
52-wk High
$4.09
52-wk Low
$1.49

Chart for

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: --
Market Cap(Mil.): $121.92
Shares Outstanding(Mil.): 74.34
Dividend: --
Yield (%): --

Financials

  SRRA.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.61 -- --
ROI: -31.66 1.96 12.83
ROE: -31.66 1.12 14.95

BRIEF-Sierra Oncology Reports Qtrly Loss Per Share $0.19

* SIERRA ONCOLOGY INC - SRA737 MONOTHERAPY PHASE 1/2 TRIAL EXPANDED TO ENROLL CCNE1-DRIVEN OVARIAN CANCER COHORT

May 10 2018

Earnings vs. Estimates